Clinical study of 81 cases of"Mamushi"viper bite during the past 11 years

Nanae Kimura, Noriko Okabe, Rieko Futamura-Nakagawa, Futoshi Koda, Akihiko Izumo, Masutaka Furue

Research output: Contribution to journalArticle

Abstract

We reviewed a total of 81 Mamushi viper (Gloydius blomhoffii) bite patients (51 males and 30 females) who required hospitalization from 2004 to 2014. Their average age was 57.3 years and 21 patients were in their sixties, which was the largest age group by decade. The most prevalent season for bites was between July and October. The onset time showed twin peaks, 46 cases were bitten between 4 p.m. to 12 a.m. hours and 16 cases were bitten between 8 a.m. to 12 p.m. hours. Mamushi bites occurred most frequently at farms (21 cases), followed by urban neighborhoods (14 cases). The main site of injury was the fingers (43 cases), followed by the foot or heel (16 cases). As many as 74 cases arrived at the hospital within 6 hours after onset. On their first visit, the severity tended to be mild (GradeI; 19 cases, Grade II; 38 cases). However, the peak severity became gradually higher (Grade III ; 27 cases, Grade IV; 25 cases). Patients with the more severe grades of injury tended to manifest higher serum levels of creatine kinase and longer hospitalization periods. None of the cases resulted in death or disseminated intravascular coagulation, however, 1 case developed renal failure and 6 cases developed diplopia. Seventy of the 81 cases were treated with Cepharanthine® and 45 with systemic corticosteroid. Antivenom was injected in 52 cases by intravenous administration. In addition, 78 cases were treated with antibiotics to prevent secondary infection. Prevention therapy for tetanus was carried out in 56 cases.

Original languageEnglish
Pages (from-to)584-588
Number of pages5
JournalNishinihon Journal of Dermatology
Volume77
Issue number6
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Bites and Stings
Hospitalization
Finger Injuries
Antivenins
Diplopia
Heel
Disseminated Intravascular Coagulation
Tetanus
Creatine Kinase
Coinfection
Intravenous Administration
Renal Insufficiency
Foot
Adrenal Cortex Hormones
Age Groups
Anti-Bacterial Agents
Wounds and Injuries
Serum
Clinical Studies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Clinical study of 81 cases of"Mamushi"viper bite during the past 11 years. / Kimura, Nanae; Okabe, Noriko; Futamura-Nakagawa, Rieko; Koda, Futoshi; Izumo, Akihiko; Furue, Masutaka.

In: Nishinihon Journal of Dermatology, Vol. 77, No. 6, 01.01.2015, p. 584-588.

Research output: Contribution to journalArticle

Kimura, Nanae ; Okabe, Noriko ; Futamura-Nakagawa, Rieko ; Koda, Futoshi ; Izumo, Akihiko ; Furue, Masutaka. / Clinical study of 81 cases of"Mamushi"viper bite during the past 11 years. In: Nishinihon Journal of Dermatology. 2015 ; Vol. 77, No. 6. pp. 584-588.
@article{3671e1f0fa884a1886675e11a5cc0524,
title = "Clinical study of 81 cases of{"}Mamushi{"}viper bite during the past 11 years",
abstract = "We reviewed a total of 81 Mamushi viper (Gloydius blomhoffii) bite patients (51 males and 30 females) who required hospitalization from 2004 to 2014. Their average age was 57.3 years and 21 patients were in their sixties, which was the largest age group by decade. The most prevalent season for bites was between July and October. The onset time showed twin peaks, 46 cases were bitten between 4 p.m. to 12 a.m. hours and 16 cases were bitten between 8 a.m. to 12 p.m. hours. Mamushi bites occurred most frequently at farms (21 cases), followed by urban neighborhoods (14 cases). The main site of injury was the fingers (43 cases), followed by the foot or heel (16 cases). As many as 74 cases arrived at the hospital within 6 hours after onset. On their first visit, the severity tended to be mild (GradeI; 19 cases, Grade II; 38 cases). However, the peak severity became gradually higher (Grade III ; 27 cases, Grade IV; 25 cases). Patients with the more severe grades of injury tended to manifest higher serum levels of creatine kinase and longer hospitalization periods. None of the cases resulted in death or disseminated intravascular coagulation, however, 1 case developed renal failure and 6 cases developed diplopia. Seventy of the 81 cases were treated with Cepharanthine{\circledR} and 45 with systemic corticosteroid. Antivenom was injected in 52 cases by intravenous administration. In addition, 78 cases were treated with antibiotics to prevent secondary infection. Prevention therapy for tetanus was carried out in 56 cases.",
author = "Nanae Kimura and Noriko Okabe and Rieko Futamura-Nakagawa and Futoshi Koda and Akihiko Izumo and Masutaka Furue",
year = "2015",
month = "1",
day = "1",
doi = "10.2336/nishinihonhifu.77.584",
language = "English",
volume = "77",
pages = "584--588",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "6",

}

TY - JOUR

T1 - Clinical study of 81 cases of"Mamushi"viper bite during the past 11 years

AU - Kimura, Nanae

AU - Okabe, Noriko

AU - Futamura-Nakagawa, Rieko

AU - Koda, Futoshi

AU - Izumo, Akihiko

AU - Furue, Masutaka

PY - 2015/1/1

Y1 - 2015/1/1

N2 - We reviewed a total of 81 Mamushi viper (Gloydius blomhoffii) bite patients (51 males and 30 females) who required hospitalization from 2004 to 2014. Their average age was 57.3 years and 21 patients were in their sixties, which was the largest age group by decade. The most prevalent season for bites was between July and October. The onset time showed twin peaks, 46 cases were bitten between 4 p.m. to 12 a.m. hours and 16 cases were bitten between 8 a.m. to 12 p.m. hours. Mamushi bites occurred most frequently at farms (21 cases), followed by urban neighborhoods (14 cases). The main site of injury was the fingers (43 cases), followed by the foot or heel (16 cases). As many as 74 cases arrived at the hospital within 6 hours after onset. On their first visit, the severity tended to be mild (GradeI; 19 cases, Grade II; 38 cases). However, the peak severity became gradually higher (Grade III ; 27 cases, Grade IV; 25 cases). Patients with the more severe grades of injury tended to manifest higher serum levels of creatine kinase and longer hospitalization periods. None of the cases resulted in death or disseminated intravascular coagulation, however, 1 case developed renal failure and 6 cases developed diplopia. Seventy of the 81 cases were treated with Cepharanthine® and 45 with systemic corticosteroid. Antivenom was injected in 52 cases by intravenous administration. In addition, 78 cases were treated with antibiotics to prevent secondary infection. Prevention therapy for tetanus was carried out in 56 cases.

AB - We reviewed a total of 81 Mamushi viper (Gloydius blomhoffii) bite patients (51 males and 30 females) who required hospitalization from 2004 to 2014. Their average age was 57.3 years and 21 patients were in their sixties, which was the largest age group by decade. The most prevalent season for bites was between July and October. The onset time showed twin peaks, 46 cases were bitten between 4 p.m. to 12 a.m. hours and 16 cases were bitten between 8 a.m. to 12 p.m. hours. Mamushi bites occurred most frequently at farms (21 cases), followed by urban neighborhoods (14 cases). The main site of injury was the fingers (43 cases), followed by the foot or heel (16 cases). As many as 74 cases arrived at the hospital within 6 hours after onset. On their first visit, the severity tended to be mild (GradeI; 19 cases, Grade II; 38 cases). However, the peak severity became gradually higher (Grade III ; 27 cases, Grade IV; 25 cases). Patients with the more severe grades of injury tended to manifest higher serum levels of creatine kinase and longer hospitalization periods. None of the cases resulted in death or disseminated intravascular coagulation, however, 1 case developed renal failure and 6 cases developed diplopia. Seventy of the 81 cases were treated with Cepharanthine® and 45 with systemic corticosteroid. Antivenom was injected in 52 cases by intravenous administration. In addition, 78 cases were treated with antibiotics to prevent secondary infection. Prevention therapy for tetanus was carried out in 56 cases.

UR - http://www.scopus.com/inward/record.url?scp=84962424979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962424979&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.77.584

DO - 10.2336/nishinihonhifu.77.584

M3 - Article

AN - SCOPUS:84962424979

VL - 77

SP - 584

EP - 588

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 6

ER -